Vol 66, No 2 (2015)

Date published: 2015-05-01

Table of Contents

open access

Review Article

Primary hyperparathyroidism due to parathyroid cancer — a diagnostic and management challenge

Anna Dąbrowska, Jerzy Tarach, Agnieszka Zwolak

Review paper

DOI: 10.5603/EP.2015.0023
Pubmed: 25931046
Endokrynol Pol 2015;66(2):150-167.
Reviews — Postgraduate Education

Amiodarone and the thyroid

Agata Jabrocka-Hybel, Tomasz Bednarczuk, Luigi Bartalena, Dorota Pach, Marek Ruchała, Grzegorz Kamiński, Marta Kostecka-Matyja, Alicja Hubalewska-Dydejczyk

Review paper

DOI: 10.5603/EP.2015.0025
Pubmed: 25931048
Endokrynol Pol 2015;66(2):176-196.
Original Paper

Evaluation of adipocytokines in children with chronic kidney disease

Maria Szczepańska, Edyta Machura, Piotr Adamczyk, Elżbieta Świętochowska, Elżbieta Trembecka-Dubel, Katarzyna Lipiec, Agnieszka Jędzura, Katarzyna Ziora

Original paper

DOI: 10.5603/EP.2015.0015
Pubmed: 25931038
Endokrynol Pol 2015;66(2):100-107.

Visfatin concentrations in obese patients in relation to the presence of newly diagnosed glucose metabolism disorders

Anna Kamińska, Ewa Kopczyńska, Maciej Bieliński, Alina Borkowska, Roman Junik

Original paper

DOI: 10.5603/EP.2015.0016
Pubmed: 25931039
Endokrynol Pol 2015;66(2):108-113.

Comparison of the effects of short-term hypolipidaemic treatment on plasma adipokine levels in men and women with isolated hypercholesterolaemia

Robert Krysiak, Witold Żmuda, Bogdan Marek, Bogusław Okopień

Original paper

DOI: 10.5603/EP.2015.0017
Pubmed: 25931040
Endokrynol Pol 2015;66(2):114-120.

The prevalence of somatic RAS mutations in medullary thyroid cancer — a Polish population study

Malgorzata Oczko-Wojciechowska, Aleksandra Pfeifer, Dagmara Rusinek, Agnieszka Pawlaczek, Jadwiga Zebracka-Gala, Malgorzata Kowalska, Monika Kowal, Michal Swierniak, Jolanta Krajewska, Tomasz Gawlik, Ewa Chmielik, Agnieszka Czarniecka, Sylwia Szpak-Ulczok, Barbara Jarząb

Original paper

DOI: 10.5603/EP.2015.0018
Pubmed: 25931041
Endokrynol Pol 2015;66(2):121-125.

Radioiodine therapy for Graves’ disease — retrospective analysis of efficacy factors

Piotr Szumowski, Saeid Abdelrazek, Agnieszka Kociura Sawicka, Małgorzata Mojsak, Jerzy Kostecki, Monika Sykała, Janusz Myśliwiec

Original paper

DOI: 10.5603/EP.2015.0019
Pubmed: 25931042
Endokrynol Pol 2015;66(2):126-131.

The role of Epstein-Barr virus infection in the development of autoimmune thyroid diseases

Andrea Janegova, Pavol Janega, Boris Rychly, Kristina Kuracinova, Pavel Babal

Original paper

DOI: 10.5603/EP.2015.0020
Pubmed: 25931043
Endokrynol Pol 2015;66(2):132-136.

The usefulness of the GHRH stimulation test in the diagnostics of growth hormone deficiency in children

Monika Obara-Moszyńska, Marek Niedziela

Original paper

DOI: 10.5603/EP.2015.0021
Pubmed: 25931044
Endokrynol Pol 2015;66(2):137-141.

Dosage and costs of lanreotide Autogel 120 mg administered as part of routine acromegaly care in Poland — two years of data from Lanro-Study

Ewa Orlewska, Beata Kos-Kudla, Jerzy Sowinski, Krzysztof Sworczak, Wojciech Zgliczynski, Lanro-Study Group

Original paper

DOI: 10.5603/EP.2015.0022
Pubmed: 25931045
Endokrynol Pol 2015;66(2):142-148.
Case report

Bruck syndrome — a rare syndrome of bone fragility and joint contracture and novel homozygous FKBP10 mutation

Hossein Moravej, Hamdollah Karamifar, Zohreh Karamizadeh, Gholamhossein Amirhakimi, Sepideh Atashi, Shiva Nasirabadi

Case report

DOI: 10.5603/EP.2015.0024
Pubmed: 25931047
Endokrynol Pol 2015;66(2):170-174.



Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Via MedicaWydawcą jest  VM Media Group sp. z o.o., Grupa Via Medica, ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl